Spyre Therapeutics, Inc. Common Stock
$85.69
▼ 1.40
(-1.61%)
Volume: 560,049
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
29
- 21d momentum -8.5%
- MA aligned bearish
- RSI 36
🎯
Pullback
62
- Near lower Bollinger band
- -4.2% vs 20MA
💎
Value
58
- -22% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)36.0
MACD-0.113
MA trendBearish
ATR5.14%
21d mom.-8.5%
63d mom.-2.5%
vs 20MA-4.2%
RVOL(20)0.42×
52w low · 15
52w high · 110
-22.2% from 52-week high
20d support 83
· resistance 95
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$7.7B
PER—
PBR6.97
PSR—
EPS$-1.70
ROE-13.6%
ROA-12.8%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-27.70
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -5.05% | -8.46% | -2.50% | +80.32% | +404.06% | +180.22% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -3.70%, daily vol 2.96%. Spyre Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.